Potent α-amylase inhibitory activity of Indian Ayurvedic medicinal plants.
BACKGROUND
Indian medicinal plants used in the Ayurvedic traditional system to treat diabetes are a valuable source of novel anti-diabetic agents. Pancreatic α-amylase inhibitors offer an effective strategy to lower the levels of post-prandial hyperglycemia via control of starch breakdown. In this study, seventeen Indian medicinal plants with known hypoglycemic properties were subjected to sequential solvent extraction and tested for α-amylase inhibition, in order to assess and evaluate their inhibitory potential on PPA (porcine pancreatic α-amylase). Preliminary phytochemical analysis of the lead extracts was performed in order to determine the probable constituents.


METHODS
Analysis of the 126 extracts, obtained from 17 plants (Aloe vera (L.) Burm.f., Adansonia digitata L., Allium sativum L., Casia fistula L., Catharanthus roseus (L.) G. Don., Cinnamomum verum Persl., Coccinia grandis (L.) Voigt., Linum usitatisumum L., Mangifera indica L., Morus alba L., Nerium oleander L., Ocimum tenuiflorum L., Piper nigrum L., Terminalia chebula Retz., Tinospora cordifolia (Willd.) Miers., Trigonella foenum-graceum L., Zingiber officinale Rosc.) for PPA inhibition was initially performed qualitatively by starch-iodine colour assay. The lead extracts were further quantified with respect to PPA inhibition using the chromogenic DNSA (3, 5-dinitrosalicylic acid) method. Phytochemical constituents of the extracts exhibiting≥ 50% inhibition were analysed qualitatively as well as by GC-MS (Gas chromatography-Mass spectrometry).


RESULTS
Of the 126 extracts obtained from 17 plants, 17 extracts exhibited PPA inhibitory potential to varying degrees (10%-60.5%) while 4 extracts showed low inhibition (< 10%). However, strong porcine pancreatic amylase inhibitory activity (> 50%) was obtained with 3 isopropanol extracts. All these 3 extracts exhibited concentration dependent inhibition with IC50 values, viz., seeds of Linum usitatisumum (540 μgml-1), leaves of Morus alba (1440 μgml-1) and Ocimum tenuiflorum (8.9 μgml-1). Acarbose as the standard inhibitor exhibited an IC50 (half maximal inhibitory concentration)value of 10.2 μgml-1. Phytochemical analysis revealed the presence of alkaloids, tannins, cardiac glycosides, flavonoids, saponins and steroids with the major phytoconstituents being identified by GC-MS.


CONCLUSIONS
This study endorses the use of these plants for further studies to determine their potential for type 2 diabetes management. Results suggests that extracts of Linum usitatisumum, Morus alba and Ocimum tenuiflorum act effectively as PPA inhibitors leading to a reduction in starch hydrolysis and hence eventually to lowered glucose levels.
Institute of Bioinformatics and Biotechnology, University of Pune, India.
Sudha
S
P
Smita S
SS
Zinjarde
Shobha Y
SY
Bhargava
Ameeta R
AR
Kumar
D020909:Acarbose / Q000494:pharmacology; D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D019597:Flax / Q000737:chemistry*; D007194:India; D020128:Inhibitory Concentration 50; D008515:Medicine, Ayurvedic; D031625:Morus / Q000737:chemistry*; D031339:Ocimum / Q000737:chemistry*; D008517:Phytotherapy; D010936:Plant Extracts / Q000737:chemistry / Q000494:pharmacology*; D010946:Plants, Medicinal / Q000737:chemistry; D013552:Swine; D000516:alpha-Amylases / Q000037:antagonists & inhibitors*
D010936:Plant Extracts; D000516:alpha-Amylases; D020909:Acarbose
Diabetes Res Clin Pract. 2001 Jun;52(3):193-204
11323089
Phytother Res. 2005 Mar;19(3):203-6
15934022
Anal Biochem. 2006 Apr 1;351(1):146-8
16500607
Diabetologia. 1984 Apr;26(4):278-81
6376235
Fitoterapia. 2007 Jun;78(4):323-6
17499940
Indian J Pharmacol. 2008 Jan;40(1):15-8
21264155
Mini Rev Med Chem. 2010 Apr;10(4):315-31
20470247
Indian J Exp Biol. 1993 Nov;31(11):891-3
8112763
CMAJ. 2005 Jan 18;172(2):213-26
15655244
Mayo Clin Proc. 1986 Jun;61(6):442-7
2423813
World Health Organ Tech Rep Ser. 1980;646:1-80
6771926
Indian J Clin Biochem. 2004 Jul;19(2):152-5
23105475
Evid Based Complement Alternat Med. 2011;2011:810207
18955350
Protein Sci. 1995 Sep;4(9):1730-42
8528071
Altern Ther Health Med. 2004 Jan-Feb;10(1):44-50
14727499
BMC Complement Altern Med. 2003 Sep 2;3:4
12950994
Int J Food Sci Nutr. 2009;60 Suppl 6:126-36
19548163
Phytomedicine. 2006 Nov;13(9-10):624-9
17085291
J Ethnopharmacol. 2006 Jun 15;106(1):1-28
16678368
Phytother Res. 2006 Sep;20(9):764-72
16807883
Saudi Pharm J. 2009 Jul;17(3):209-15
23964163
J Agric Food Chem. 2009 Oct 14;57(19):9133-40
19761189
Prog Lipid Res. 1989;28(4):303-36
2701896
Afr J Tradit Complement Altern Med. 2007 Oct 27;5(1):1-17
20162049
Bioinformation. 2006 Apr 13;1(4):130-1
17597872
BMC Complement Altern Med. 2006 May 07;6:17
16677399
Indian J Physiol Pharmacol. 2005 Jan;49(1):65-71
15881860
J Ethnopharmacol. 2002 Jun;81(1):81-100
12020931
Chembiochem. 2008 Feb 15;9(3):433-8
18214874
Biochem J. 1993 May 15;292 ( Pt 1):267-70
8389127
J Nutr Sci Vitaminol (Tokyo). 2007 Apr;53(2):166-73
17616005
Diabetes Metab Res Rev. 1999 Jul-Aug;15(4):289-96
10495478